High salt and increased blood pressure variability as co-morbid risk factors for cognitive decline.
Description: The rapid growth of the aging population parallels an increased prevalence of cognitive impairment, raising concerns about the health management and financial burden associated with this condition. Thus, it is critically important to address the modifiable risk factors that can mitigate the onset and progression of cognitive decline. Among these, blood pressure regulation and a healthy diet top the list. Aberrant blood pressure fluctuations lead to increased blood pressure variability (BPV), an early predictor of hypertension and cognitive decline later in life. In addition, excessive salt consumption is also a key contributor to hypertension. Both BPV and a high salt diet (HSD) contribute to cognitive decline. However, because these factors are studied independently in many instances, how their co-existence contributes to disease progression is poorly understood. The main goal of this application is to elucidate the impact of a HSD, in combination with BPV, has on vascular function and brain health. An early marker of cognitive impairment is the breakdown of the blood-brain barrier (BBB). Loss of BBB integrity is accompanied by the disruption of these tight junctions by specialized enzymes such as those from the metalloproteinase (MMP) family. Patients with high BPV show increased levels of MMPs, especially MMP-9. However, how increased BPV causes BBB degradation or the main cellular contributors of MMP-9 has not been elucidated. Additionally, whether a HSD contributes to BPV and exacerbates cognitive decline is unknown. We propose to test the central hypothesis that a high salt diet, in combination with BPV, during midlife triggers the release of MMP-9, contributing to the degradation of the BBB, which leads to cognitive decline. In a recently developed murine model of high BPV, subjected to a HSD, we will use a multidisciplinary approach to explore the following Aims. In Aim 1, we will test the hypothesis that a HSD combined with BPV, lowers the threshold for the development of hypertension and exacerbates BPV-induced cognitive decline. In Aim 2, we will test the hypothesis that a HSD combined with BPV, decreases BBB integrity via MMP-9. The proposed studies will explain how excess dietary salt intake and robust blood pressure fluctuations diminish neurovascular function. Data obtained may help develop therapeutic strategies to maintain BBB integrity and delay aged-dependent cognitive dysfunction.
Funder: American Heart Association
Amount: $151,600
Funding type: fellowship
Funder scheme: Postdoctoral Fellowship
Start date: 2024-01-01
End date: 2024-06-01
Investigator: Perenkita Mendiola (lead)
Institutions: Augusta University, Augusta University Research Institute, Inc.
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Funded outputs count: 1
Funder award ID: 24POST1196351
OpenAlex ID: G5343878707
